Table 3.
Regions Showing Direct Comparison of Treatment Effects
Brain Region | MNI Coordinates |
Z score | Significance (p Value) | ||
---|---|---|---|---|---|
x | y | z | |||
Chocolate in Mouth: Reboxetine > Citalopram | |||||
Ventral striatum | −6 | 12 | −4 | 4.64 | .07 |
Putamen | −22 | 14 | −10 | 4.29 | .005 |
Caudate | 10 | 22 | −2 | 4.85 | <.001 |
MOFC | 2 | 32 | −24 | 3.44 | .01a |
Sight of Chocolate: | |||||
Ventral striatum | 8 | 10 | −4 | 4.02 | .001 |
Insula | 38 | −6 | −6 | 5.02 | <.001 |
Pregenual cing | 0 | 48 | −2 | 4.66 | <.001 |
Amygdala | 18 | −8 | −16 | 4.47 | .006 |
Strawberry in Mouth: | |||||
Insula | −38 | 8 | −12 | 4.52 | <.001 |
p value clusters whole brain fully corrected (family-wise error).
MNI, Montreal Neurological Institute; MOFC, medial orbitofrontal cortex; cing, cingulate.
False discovery rate small volume correction.